TuHURA Biosciences (HURA) Accumulated Depreciation (2021 - 2026)
TuHURA Biosciences' (HURA) quarterly Accumulated Depreciation came in at $2.2 million in Q1 2026, up 3.84% year-on-year from $2.1 million in Q1 2025, and up 1.09% quarter-over-quarter from $2.2 million in Q4 2025.
TuHURA Biosciences (HURA) Accumulated Depreciation (2021 - 2026) Analysis & Trends
TuHURA Biosciences' Accumulated Depreciation history runs 5 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- On a quarterly basis, Accumulated Depreciation rose 3.84% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $2.2 million, a 3.84% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 3.41% from the prior year.
- Accumulated Depreciation advanced to $2.2 million in Q1 2026 per HURA's latest filing, from $2.2 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $2.2 million in Q1 2026 and bottomed at $2.0 million in Q4 2023.
- The 4-year median for Accumulated Depreciation is $2.1 million (2025), against an average of $2.1 million.
- Across the five-year window, Accumulated Depreciation rose 5.92% in 2024 and increased 3.41% in 2025, its largest moves.
- Year by year, Accumulated Depreciation stood at $2.0 million in 2023, then advanced by 5.92% to $2.1 million in 2024, then increased by 3.41% to $2.2 million in 2025, then gained by 1.09% to $2.2 million in 2026.
- Per Business Quant, the three latest HURA Accumulated Depreciation figures stand at $2.2 million (Q1 2026), $2.2 million (Q4 2025), and $2.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 2.11 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Dec 31, 2023 | 1.97 Mn |
| Mar 31, 2021 | 15,000.00 |